These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2299641)

  • 41. N-methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
    Glennon RA; Titeler M; Seggel MR; Lyon RA
    J Med Chem; 1987 May; 30(5):930-2. PubMed ID: 3572981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurochemical profile of eltoprazine.
    Schipper J; Tulp MT; Sijbesma H
    Drug Metabol Drug Interact; 1990; 8(1-2):85-114. PubMed ID: 1982626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site.
    Pazos A; Hoyer D; Palacios JM
    Eur J Pharmacol; 1984 Nov; 106(3):539-46. PubMed ID: 6519175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
    Fischette CT; Nock B; Renner K
    Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new 5-hydroxy-indole derivative with preferential affinity for 5-HT1B binding sites.
    Boulenguez P; Chauveau J; Segu L; Morel A; Lanoir J; Delaage M
    Eur J Pharmacol; 1991 Feb; 194(1):91-8. PubMed ID: 2060597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
    Pranzatelli MR; Murthy JN; Pluchino RS
    J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A single point mutation increases the affinity of serotonin 5-HT1D alpha, 5-HT1D beta, 5-HT1E and 5-HT1F receptors for beta-adrenergic antagonists.
    Adham N; Tamm JA; Salon JA; Vaysse PJ; Weinshank RL; Branchek TA
    Neuropharmacology; 1994; 33(3-4):387-91. PubMed ID: 7984276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of [3H]5-hydroxytryptamine binding to iris-ciliary body tissue of the rabbit.
    Chidlow G; De Santis LM; Sharif NA; Osborne NN
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2238-45. PubMed ID: 7558717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.
    Hoyer D; Pazos A; Probst A; Palacios JM
    Brain Res; 1986 Jun; 376(1):97-107. PubMed ID: 2941113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presynaptic displacement of serotonin by alpha-methyl-5-hydroxytryptamine in the nucleus tractus solitarius of the rat.
    Helfman CC; Anderson GF; Barraco RA
    Neurosci Lett; 1995 Apr; 189(2):65-8. PubMed ID: 7609920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.
    Rinaldi-Carmona M; Congy C; Santucci V; Simiand J; Gautret B; Neliat G; Labeeuw B; Le Fur G; Soubrie P; Breliere JC
    J Pharmacol Exp Ther; 1992 Aug; 262(2):759-68. PubMed ID: 1501121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Synthesis and pharmacological study of radioiodinated serotonin derivative specific of 5-HT1B and 5-HT1D binding sites of the central nervous system].
    Segu L; Chauveau J; Boulenguez P; Morel A; Lanoir J; Delaage M
    C R Acad Sci III; 1991; 312(13):655-61. PubMed ID: 1913239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of serotonin receptors in the iris + ciliary body of the albino rabbit.
    Mallorga P; Sugrue MF
    Curr Eye Res; 1987 Mar; 6(3):527-32. PubMed ID: 3581873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Classification of serotonin receptors.
    Göthert M; Schlicker E
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S3-7. PubMed ID: 2446065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors.
    Saxena PR; Lawang A
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):235-52. PubMed ID: 2933009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A preliminary investigation of the psychoactive agent 4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse.
    Glennon RA; Titeler M; Lyon RA
    Pharmacol Biochem Behav; 1988 Jul; 30(3):597-601. PubMed ID: 3211969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3'-NAP-amino-PAT.
    Emerit MB; Gozlan H; Marquet A; Hamon M
    Eur J Pharmacol; 1986 Aug; 127(1-2):67-81. PubMed ID: 2944752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes.
    De Keyser J; Walraevens H; Convents A; Ebinger G; Vauquelin G
    Eur J Pharmacol; 1989 Mar; 162(3):437-45. PubMed ID: 2568263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.